GMAB
Genmab A
$28.80
−$0.07 (−0.24%)Jul 27, 2026
Key metrics
The numbers that frame GMAB today
- Market cap
- $18.50B
- P/E (TTM)
- 22.5
- EV / FCF
- 25.6
- Gross margin
- 93.3%
- EV / Sales
- 5.7
- ROIC
- 34.2%
- Div yield
- 0%
- Debt / equity
- 0.9
- 52wk Low
- $21.00
- 52wk High
- $35.43
Growth
Revenue and earnings trend for GMAB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about GMAB
Is Genmab A a good buy?
Yes. Genmab A has excellent quality, and it outweighs the weak momentum here. Growth looks mixed. The support signal is useful, but not decisive. We think Genmab A is selling at a low price.
What is the market capitalization of GMAB?
Genmab A's market capitalization is $18.50B.
What is the P/E ratio for GMAB stock?
Genmab A's current P/E ratio is 22.5.
What is the 52-week high for GMAB stock?
The 52-week high for Genmab A is $35.43. The current close of $28.80 is 18.7% below that high.
What is the 52-week low for GMAB stock?
The 52-week low for Genmab A is $21.00. The current close of $28.80 is 37.2% above that low.
Does GMAB stock pay dividends?
Genmab A does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for GMAB?
Genmab A's Debt / Equity ratio is 0.94.